GO
Loading...

Celgene Corp

More

  • Caterpillar and D.R. Horton are big market movers Thursday, 24 Apr 2014 | 4:42 PM ET

    NEW YORK— Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq Stock Market:. Zimmer Holdings Inc., up $10.52 to $101.97. Caterpillar Inc., up $1.90 to $105.28.

  • April 24- Celgene Corp on Thursday reported a slightly higher-than-expected first-quarter profit on increased sales of its flagship multiple myeloma drug Revlimid and other oncology products. Excluding special items, Celgene had adjusted earnings of $1.67 per share, topping analysts' average expectations by 2 cents, according to Thomson Reuters I/B/E/S.

  • Final Glance: Biotechnology companies Wednesday, 23 Apr 2014 | 6:03 PM ET

    Amgen Inc. fell $5.99 or 5.0 percent, to $113.32. Biogen Idec rose$. 55 or. 2 percent, to $306.75. Celgene Corp. fell $1.82 or 1.2 percent, to $144.82.

  • Midday Glance: Biotechnology companies Wednesday, 23 Apr 2014 | 1:37 PM ET

    Amgen Inc. fell $6.17 or 5.2 percent, to $113.13. Biogen Idec fell $5.61 or 1.8 percent, to $300.59. Celgene Corp. fell$. 59 or. 4 percent, to $146.05.

  • Early Glance: Biotechnology companies Wednesday, 23 Apr 2014 | 10:29 AM ET

    Amgen Inc. fell $5.56 or 4.7 percent, to $113.74. Biogen Idec fell $5.05 or 1.6 percent, to $301.16. Celgene Corp. fell$. 18 or. 1 percent, to $146.46.

  • Drug firm exec gets 16 months in inside-trade case Tuesday, 22 Apr 2014 | 11:01 AM ET

    Lazorchak was director of financial reporting at Celgene Corp. when he was arrested in November 2012 along with five other people. From 2007 to 2012, Lazorchak regularly disclosed nonpublic information about Celgene's anticipated corporate acquisitions, numerous quarterly earnings results, and regulatory news to Cupo, prosecutors said.

  • Final Glance: Biotechnology companies Monday, 21 Apr 2014 | 6:02 PM ET

    Amgen Inc. rose $1.56 or 1.4 percent, to $117.02. Biogen Idec rose $7.44 or 2.6 percent, to $297.98. Celgene Corp. rose $2.32 or 1.6 percent, to $143.83.

  • Midday Glance: Biotechnology companies Monday, 21 Apr 2014 | 1:20 PM ET

    Amgen Inc. rose$. 89 or. 8 percent, to $116.35. Biogen Idec rose $3.44 or 1.2 percent, to $293.98. Celgene Corp. rose $1.03 or. 7 percent, to $142.54.

  • Early Glance: Biotechnology companies Monday, 21 Apr 2014 | 10:31 AM ET

    Amgen Inc. rose$. 91 or. 8 percent, to $116.37. Biogen Idec rose $3.58 or 1.2 percent, to $294.12. Celgene Corp. rose $1.63 or 1.2 percent, to $143.14.

  • Here's what will drive stocks this week Sunday, 20 Apr 2014 | 4:46 PM ET

    About 150 S&P 500 companies are scheduled to release results this week, in an earnings season that has been mediocre.

  • Final Glance: Biotechnology companies Wednesday, 16 Apr 2014 | 6:02 PM ET

    Amgen Inc. rose$. 54 or. 5 percent, to $115.54. Biogen Idec rose $5.99 or 2.1 percent, to $291.48. Celgene Corp. rose $2.02 or 1.4 percent, to $141.86.

  • Midday Glance: Biotechnology companies Wednesday, 16 Apr 2014 | 1:30 PM ET

    Amgen Inc. rose$. 17 or. 1 percent, to $115.17. Biogen Idec rose $5.59 or 2.0 percent, to $291.08. Celgene Corp. rose $1.52 or 1.1 percent, to $141.36.

  • Early Glance: Biotechnology companies Wednesday, 16 Apr 2014 | 10:27 AM ET

    Amgen Inc. fell$. 34 or. 3 percent, to $114.67. Biogen Idec rose $2.08 or. 7 percent, to $287.57. Celgene Corp. rose $1.35 or 1.0 percent, to $141.19.

  • Final Glance: Biotechnology companies Monday, 14 Apr 2014 | 6:01 PM ET

    Amgen Inc. rose $1.38 or 1.2 percent, to $113.32. Biogen Idec rose $5.52 or 2.0 percent, to $279.52. Celgene Corp. rose $1.16 or. 8 percent, to $138.06.

  • Biotechs in the green after last week's carnage Monday, 14 Apr 2014 | 2:58 PM ET

    Shares of Biogen Idec, Celgene, Gilead Sciences, and Lexicon Pharmaceuticals recovered from last week's selloff.

  • Midday Glance: Biotechnology companies Monday, 14 Apr 2014 | 2:08 PM ET

    Amgen Inc. rose $2.12 or 1.9 percent, to $114.06. Biogen Idec rose $6.40 or 2.3 percent, to $280.40. Celgene Corp. rose $1.64 or 1.2 percent, to $138.54.

  • Early Glance: Biotechnology companies Monday, 14 Apr 2014 | 10:21 AM ET

    Amgen Inc. rose$. 01 or percent, to $111.95. Biogen Idec rose $3.06 or 1.1 percent, to $277.06. Celgene Corp. rose $1.60 or 1.2 percent, to $138.50.

  • Final Glance: Biotechnology companies Friday, 11 Apr 2014 | 6:02 PM ET

    Amgen Inc. fell $2.17 or 1.9 percent, to $111.94. Biogen Idec fell $13.35 or 4.6 percent, to $274.00. Celgene Corp. fell $3.08 or 2.2 percent, to $136.90.

  • Midday movers: Netflix, Tesla Motors, CBS & More Thursday, 10 Apr 2014 | 12:45 PM ET

    Some of Thursday's midday movers:

  • CNBC's Jim Cramer speaks with Robert Hugin, Celgene chairman & CEO, about America's need to build a stronger and more sustainable ecosystem of innovation to continue as the world leader in biomedical innovation.

Most Popular Video

Thursday, 24 Apr 2014 | 2:30 PM ET

Sell in May? It's an old cliché but the problem is it's sometimes right! But earnings keep rolling in better than expected. CNBC's Patti Domm explains.

Thursday, 24 Apr 2014 | 1:16 PM ET

Discussing whether boards of directors are necessary for companies, and the importance of them pushing back, with Stuart Grant of Grant & Eisenhofer, and Brad Feld, author of "Startup Boards."

Thursday, 24 Apr 2014 | 1:33 PM ET

CNBC's Diana Olick reports DR Horton announced a new bargain brand targeted at the entry-level buyer.